Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy (SHEARWAVE)
Primary Purpose
Liver Fibrosis, Children
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Shearwave electrography
Sponsored by
About this trial
This is an interventional diagnostic trial for Liver Fibrosis focused on measuring Diagnostic, Liver fibrosis, Ishak score, Fibrotest, ShearWave elastography, Liver biopsies
Eligibility Criteria
Inclusion Criteria:
- age < 18 years;
- indication to liver biopsy;
- informed consent of both parents and child if applicable;
- social insurance
Exclusion Criteria:
-
Sites / Locations
- AP-HP, Bicêtre Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Shearwave electrography
Arm Description
Two experimental interventions will be realized in each patient in this population : Shearwave electrography (new diagnostic test of fibrosis) and Fibrotest . Moreover, liver biopsies, the gold standard for the fibrosis diagnosis is also realized in each patient within usual cares.
Outcomes
Primary Outcome Measures
liver fibrosis evaluated by the ISHAK score and morphometric evaluation
Histology is the gold standard to evaluate liver fibrosis
Secondary Outcome Measures
liver fibrosis evaluation : stiffness using SHEARWAVE elastography
Liver fibrosis evaluation using Fibrotest (Fibromax)
Full Information
NCT ID
NCT02041780
First Posted
January 20, 2014
Last Updated
September 28, 2016
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT02041780
Brief Title
Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy
Acronym
SHEARWAVE
Official Title
Non Invasive Assessment of Liver Fibrosis in Children: Evaluation of Diagnostic Performances of ShearWave Elastography (SWE) and Fibrotest®/ Fibromax® by Comparison With Fibrosis Score on Liver Biopsy
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine if SWE and Fibrotest®/ Fibromax®, alone or associated, are effective methods to assess liver fibrosis in children.
Detailed Description
Liver biopsy will be the gold standard to assess fibrosis using Ishak score and morphometric evaluation of fibrosis. All children included will have a measure of liver stiffness using SWE with 5 measures performed in the area where the biopsy is performed and 5 measures in an other place in the liver. Fibrotest®/ Fibromax® will be performed on blood sample. All exams will be done within 1 month. diagnostic performance of SWE and Fibrotest®/ Fibromax® will be assessed respectively. algorithm using the results of both technics will be tested in order to test diagnostic performance and to obtain better performances.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Fibrosis, Children
Keywords
Diagnostic, Liver fibrosis, Ishak score, Fibrotest, ShearWave elastography, Liver biopsies
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
220 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Shearwave electrography
Arm Type
Experimental
Arm Description
Two experimental interventions will be realized in each patient in this population : Shearwave electrography (new diagnostic test of fibrosis) and Fibrotest .
Moreover, liver biopsies, the gold standard for the fibrosis diagnosis is also realized in each patient within usual cares.
Intervention Type
Procedure
Intervention Name(s)
Shearwave electrography
Primary Outcome Measure Information:
Title
liver fibrosis evaluated by the ISHAK score and morphometric evaluation
Description
Histology is the gold standard to evaluate liver fibrosis
Time Frame
up to 1 month
Secondary Outcome Measure Information:
Title
liver fibrosis evaluation : stiffness using SHEARWAVE elastography
Time Frame
up 1 month
Title
Liver fibrosis evaluation using Fibrotest (Fibromax)
Time Frame
up 1 month
10. Eligibility
Sex
All
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age < 18 years;
indication to liver biopsy;
informed consent of both parents and child if applicable;
social insurance
Exclusion Criteria:
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stéphanie FRANCHI-ABELA, MD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
AP-HP, Bicêtre Hospital
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94275
Country
France
12. IPD Sharing Statement
Learn more about this trial
Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy
We'll reach out to this number within 24 hrs